Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | F2 | P00734 | 3/20 | 0.40 |
| ▸ | PRSS1 | P07477 | 3/20 | 0.40 |
| ▸ | PRSS2 | P07478 | 3/20 | 0.40 |
| ▸ | PRSS3 | P35030 | 3/20 | 0.40 |
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | CA12 | O43570 | 2/20 | 0.34 |
| ▸ | CA9 | Q16790 | 2/20 | 0.34 |
| ▸ | TAS2R14 | Q9NYV8 | 4/20 | 0.34 |
| ▸ | FABP4 | P15090 | 1/20 | 0.34 |
| ▸ | TRPM8 | Q7Z2W7 | 1/20 | 0.34 |
| ▸ | PTGES | O14684 | 1/20 | 0.34 |
| ▸ | TAS2R8 | Q9NYW2 | 1/20 | 0.34 |
| ▸ | CXCR3 | P49682 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4284694 | 0.80 | F2 (0.42) | F2PRSS1PRSS2PRSS3TSHR | |
| SCHEMBL28597888 | 0.74 | ALDH1A1 (0.32) | TSHRSMN1; SMN2ALDH1A1KMT2AMEN1 | |
| SCHEMBL1827311 | 0.73 | CA12 (0.42) | F2PRSS1PRSS2PRSS3SMN1; SMN2 | |
| SCHEMBL28609059 | 0.73 | CA1 (0.34) | TSHRALDH1A1CA9TAS2R14 | |
| SCHEMBL4291049 | 0.72 | MEN1 (0.38) | F2PRSS1PRSS2PRSS3ALDH1A1 | |
| SCHEMBL8848745 | 0.70 | CA1 (0.46) | F2PRSS1PRSS2PRSS3ALDH1A1 | |
| SCHEMBL9247098 | 0.69 | ALDH1A1 (0.34) | F2PRSS1PRSS2PRSS3TSHR | |
| SCHEMBL7693190 | 0.69 | CA1 (0.43) | F2PRSS1PRSS2PRSS3SMN1; SMN2 | |
| SCHEMBL7934327 | 0.68 | CA1 (0.45) | F2PRSS1PRSS2PRSS3SMN1; SMN2 | |
| SCHEMBL66383 | 0.68 | CA1 (0.42) | F2PRSS1PRSS2PRSS3SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070134283-A1 | Surfactant-based composition and associated methods | GENERAL ELECTRIC COMPANY (US) | 2007-06-14 | — | — | US | disclosed |
| US-7074743-B1 | Herbicidal composition comprising 4-iodo-2-[3-(4-methoxy-6-methyl-1,3,5-triazin-2-yl)ureidosulfonyl]benzoic esters | HOECHST SCHERING AGREVO GMBH (DE) | 2006-07-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070134283-A1 | Surfactant-based composition and associated methods | SGMS2, SGMS1, GEMIN4 | F2 2420/4885PRSS1 2704/4885PRSS2 3608/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.